View in EDS PDF Full Text

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.

Saved in:
Bibliographic Details
Title: Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
Authors: Wilson WH; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA., Young RM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA., Schmitz R; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA., Yang Y; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA., Pittaluga S; Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland, USA., Wright G; Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA., Lih CJ; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Shaffer AL; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA., Gerecitano J; 1] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. [2] Department of Medicine, Weill Cornell Medical College, New York, New York, USA., de Vos S; Division of Hematology and Oncology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA., Goy A; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey, USA., Kenkre VP; Division of Hematology and Medical Oncology, University of Wisconsin, Madison, Wisconsin, USA., Barr PM; James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, USA., Blum KA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Shustov A; Department of Medicine, Hematology, University of Washington School of Medicine, Seattle, Washington, USA., Advani R; Medical Oncology, Stanford University Medical Center, Stanford, California, USA., Fowler NH; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vose JM; Division of Hematology &Oncology, Department of Internal Medicine, University of Nebraska, Omaha, Nebraska, USA., Elstrom RL; Clinical Development, Genentech, Inc., South San Francisco, California, USA., Habermann TM; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Barrientos JC; Division of Hematology and Medical Oncology, Department of Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York, USA., McGreivy J; Pharmacyclics, Inc., Sunnyvale, California, USA., Fardis M; Pharmacyclics, Inc., Sunnyvale, California, USA., Chang BY; Pharmacyclics, Inc., Sunnyvale, California, USA., Clow F; Pharmacyclics, Inc., Sunnyvale, California, USA., Munneke B; Pharmacyclics, Inc., Sunnyvale, California, USA., Moussa D; Pharmacyclics, Inc., Sunnyvale, California, USA., Beaupre DM; Pharmacyclics, Inc., Sunnyvale, California, USA., Staudt LM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.
Source: Nature medicine [Nat Med] 2015 Aug; Vol. 21 (8), pp. 922-6. Date of Electronic Publication: 2015 Jul 20.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26193343
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wilson+WH%22">Wilson WH</searchLink>; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Young+RM%22">Young RM</searchLink>; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Schmitz+R%22">Schmitz R</searchLink>; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Pittaluga+S%22">Pittaluga S</searchLink>; Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Wright+G%22">Wright G</searchLink>; Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lih+CJ%22">Lih CJ</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Williams+PM%22">Williams PM</searchLink>; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Shaffer+AL%22">Shaffer AL</searchLink>; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Gerecitano+J%22">Gerecitano J</searchLink>; 1] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. [2] Department of Medicine, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22de+Vos+S%22">de Vos S</searchLink>; Division of Hematology and Oncology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Goy+A%22">Goy A</searchLink>; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Kenkre+VP%22">Kenkre VP</searchLink>; Division of Hematology and Medical Oncology, University of Wisconsin, Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Barr+PM%22">Barr PM</searchLink>; James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Blum+KA%22">Blum KA</searchLink>; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Shustov+A%22">Shustov A</searchLink>; Department of Medicine, Hematology, University of Washington School of Medicine, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Advani+R%22">Advani R</searchLink>; Medical Oncology, Stanford University Medical Center, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Fowler+NH%22">Fowler NH</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Vose+JM%22">Vose JM</searchLink>; Division of Hematology &Oncology, Department of Internal Medicine, University of Nebraska, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Elstrom+RL%22">Elstrom RL</searchLink>; Clinical Development, Genentech, Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Habermann+TM%22">Habermann TM</searchLink>; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Barrientos+JC%22">Barrientos JC</searchLink>; Division of Hematology and Medical Oncology, Department of Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York, USA.<br /><searchLink fieldCode="AU" term="%22McGreivy+J%22">McGreivy J</searchLink>; Pharmacyclics, Inc., Sunnyvale, California, USA.<br /><searchLink fieldCode="AU" term="%22Fardis+M%22">Fardis M</searchLink>; Pharmacyclics, Inc., Sunnyvale, California, USA.<br /><searchLink fieldCode="AU" term="%22Chang+BY%22">Chang BY</searchLink>; Pharmacyclics, Inc., Sunnyvale, California, USA.<br /><searchLink fieldCode="AU" term="%22Clow+F%22">Clow F</searchLink>; Pharmacyclics, Inc., Sunnyvale, California, USA.<br /><searchLink fieldCode="AU" term="%22Munneke+B%22">Munneke B</searchLink>; Pharmacyclics, Inc., Sunnyvale, California, USA.<br /><searchLink fieldCode="AU" term="%22Moussa+D%22">Moussa D</searchLink>; Pharmacyclics, Inc., Sunnyvale, California, USA.<br /><searchLink fieldCode="AU" term="%22Beaupre+DM%22">Beaupre DM</searchLink>; Pharmacyclics, Inc., Sunnyvale, California, USA.<br /><searchLink fieldCode="AU" term="%22Staudt+LM%22">Staudt LM</searchLink>; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2015 Aug; Vol. 21 (8), pp. 922-6. <i>Date of Electronic Publication: </i>2015 Jul 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26193343
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/nm.3884
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 922
    Titles:
      – TitleFull: Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wilson WH
      – PersonEntity:
          Name:
            NameFull: Young RM
      – PersonEntity:
          Name:
            NameFull: Schmitz R
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: Pittaluga S
      – PersonEntity:
          Name:
            NameFull: Wright G
      – PersonEntity:
          Name:
            NameFull: Lih CJ
      – PersonEntity:
          Name:
            NameFull: Williams PM
      – PersonEntity:
          Name:
            NameFull: Shaffer AL
      – PersonEntity:
          Name:
            NameFull: Gerecitano J
      – PersonEntity:
          Name:
            NameFull: de Vos S
      – PersonEntity:
          Name:
            NameFull: Goy A
      – PersonEntity:
          Name:
            NameFull: Kenkre VP
      – PersonEntity:
          Name:
            NameFull: Barr PM
      – PersonEntity:
          Name:
            NameFull: Blum KA
      – PersonEntity:
          Name:
            NameFull: Shustov A
      – PersonEntity:
          Name:
            NameFull: Advani R
      – PersonEntity:
          Name:
            NameFull: Fowler NH
      – PersonEntity:
          Name:
            NameFull: Vose JM
      – PersonEntity:
          Name:
            NameFull: Elstrom RL
      – PersonEntity:
          Name:
            NameFull: Habermann TM
      – PersonEntity:
          Name:
            NameFull: Barrientos JC
      – PersonEntity:
          Name:
            NameFull: McGreivy J
      – PersonEntity:
          Name:
            NameFull: Fardis M
      – PersonEntity:
          Name:
            NameFull: Chang BY
      – PersonEntity:
          Name:
            NameFull: Clow F
      – PersonEntity:
          Name:
            NameFull: Munneke B
      – PersonEntity:
          Name:
            NameFull: Moussa D
      – PersonEntity:
          Name:
            NameFull: Beaupre DM
      – PersonEntity:
          Name:
            NameFull: Staudt LM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2015 Aug
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1